Keyphrases
Comorbidity
80%
Clinical Practice Guidelines
66%
Drug Interactions
61%
Direct Treatment
55%
Disutility
55%
Drug-disease Interactions
50%
Randomized Controlled Trial
50%
Physical Condition
50%
Exclusion Rates
50%
Treatment Trials
50%
National Clinical Guidelines
50%
Health Economic Modelling
50%
Type 2 Diabetes Mellitus (T2DM)
47%
National Institutes of Health
27%
Heart Failure
27%
Clinical Population
25%
Chronic Kidney Disease
22%
Absolute Benefit
22%
Model-based Economic Evaluation
20%
Funding Sources
16%
Competing Risk of Death
16%
Co-prescribing
16%
Exclusion Criteria
16%
Cost-effectiveness
15%
Economic Model
11%
Coronary Artery Disease
11%
Discrete Event Simulation
11%
Diabetes Guidelines
11%
Guideline Development
11%
Preventive Treatment
11%
Comorbid
11%
Payoff
11%
Single Disease
11%
Patient Benefit
11%
Treatment Recommendations
11%
Evaluation Model
10%
Hypertension
8%
Trial Registration
8%
Subgroup Analysis
8%
Implicit Criteria
8%
Text Reviews
8%
Asthma
8%
Physical Health Conditions
8%
Functional Status
8%
Prospero
8%
Estimated Rates
8%
Chronic Conditions
8%
Life Expectancy
8%
Embase
8%
Risk of Bias Assessment
8%
Generalisability
8%
Data Extraction
8%
MEDLINE
8%
Chronic Obstructive Pulmonary Disease
8%
Population Aging
8%
Data Risk
8%
Older People
8%
Number of Drugs
5%
Epidemiological Data
5%
Pharmacological Treatment
5%
Highly Sensitive
5%
Primary Prevention
5%
Systematic Classification
5%
Major Depressive Disorder
5%
Economic Modeling
5%
Interactive Approach
5%
Interaction-based
5%
Modeling Project
5%
Patients with multimorbidity
5%
Treatment Burden
5%
Primary Care
5%
Relative Cost
5%
Informed Decision-making
5%
Care Pathway
5%
Drug Selection
5%
Parameter Values
5%
Inherent Uncertainty
5%
Cost-effectiveness Analysis
5%
Time to Benefit
5%
Systematic Identification
5%
Time Risk
5%
Simulation-based Model
5%
Statins
5%
Clinical Research
5%
Medicine and Dentistry
Clinical Guideline
100%
Multiple Chronic Conditions
72%
Maturity Onset Diabetes of the Young
58%
Comorbidity
53%
Randomized Controlled Trial
50%
Drug Induced Disease
50%
Systematic Review
50%
Clinical Population
50%
Drug Interaction
50%
Congestive Heart Failure
29%
Chronic Kidney Disease
23%
Diseases
19%
Subgroup Analysis
16%
Life Expectancy
16%
Asthma
16%
Functional Status
16%
Chronic Obstructive Pulmonary Disease
16%
Ischemic Heart Disease
14%
Cost-Effectiveness Analysis
14%
Care Pathway
7%
Lifespan
7%
Major Depressive Episode
7%
Clinical Research
7%
Decision Making
7%
Statin
7%
Primary Prevention
7%
Primary Health Care
7%
Pharmacological Treatment
7%
Clinician
5%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Chronic Conditions
72%
Non Insulin Dependent Diabetes Mellitus
58%
Comorbidity
53%
Drug Induced Disease
50%
Randomized Controlled Trial
50%
Drug-Drug Interaction
50%
Congestive Heart Failure
29%
Chronic Kidney Failure
23%
Diseases
19%
Life Expectancy
16%
Functional Status
16%
Chronic Obstructive Lung Disease
16%
Asthma
16%
Ischemic Heart Disease
14%
Clinical Research
7%
Major Depression
7%
Tablet
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Drug Interaction
5%